Myla, Agila merger
Myla, Inc. and Agila Specialties would, between them, have to divest 11 generic injectable drugs as a condition of Myla’s purchase of Agila from Strides Arcolab under a proposed settlement approved...To view the full article, register now.
Already a subscriber? Click here to view full article